Navigation Links
Dr. Jay Calvert MD Announces Details on New Patent-Protected Investigational Breast Implants
Date:1/27/2010

LOS ANGELES, Jan. 27 /PRNewswire/ -- Los Angeles-based plastic surgeon, Dr. Jay Calvert, posted more information about the IDEAL breast implants on his blog. He discussed the frequently asked questions about this new product and discussed when it would be available to the public for a clinical trial.

Board-certified Dr. Jay Calvert was chosen as one of the investigators of the new IDEAL breast implants. These implants are known to have the same result as that of silicone gel but are much safer. The clinical trial has begun accepting patients who are willing to undergo the procedure and commit to follow up check ups for the next 10 years.

More and more women are turning to cosmetic surgeries such as breast augmentation and rhinoplasty in order to enhance their looks. The increase in the demand for these types of operations have paved the way for new procedures and tools to be developed in order to ensure the safety of the patients. Among these new developments is the IDEAL breast implant.

"This [IDEAL breast implant] is the first improvement in the basic design of the saline-filled breast implant since it was introduced over 30 years ago,'' explained Dr. Calvert when asked about the new product. The IDEAL breast implant is saline-filled and structurally lowered in order to fit better to the chest wall. It was also designed so that it doesn't wrinkle and would feel and look natural.

The clinical trial for this new product is currently ongoing and patients are being selected to undergo the treatment. The trial program specifies that the patient must pay for the breast augmentation; however, if they are able to complete the 10-year clinical trial, then they will be able to receive some financial benefit. Dr. Calvert, MD, FACS, who is one of the surgeons performing this clinical trial, said that it is like an insurance policy; the company will put part of the patient's payment in her trust fund, and after 10 years, the trust fund is expected to grow to about 10000 U.S. Dollars. Dr. Calvert added that "women who entered the study will then have the comfort of knowing that there's money for them at the end of the study, if they do all their follow-ups and complete the study properly." Even though Dr. Calvert is optimistic about this new breast augmentation technique, he still adds that, "if problems come up and we need to draw upon that money and stop the study, then there's money there to do that."

Certified by the American Board of Plastic Surgery, Dr. Calvert also performs other cosmetic surgeries including breast augmentation, post-bariatric surgery, face-lift and rhinoplasty among others. He is based in Los Angeles, California and sees new patients at his two offices in Beverly Hills and Newport Beach.

Press Release Contact Information:

JayCalvertMD.com

1-888-895-5605

dr.calvert09@gmail.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.

SOURCE Dr. Jay Calvert MD - Los Angeles Plastic Surgeon

RELATED LINKS
http://www.JayCalvertMD.com

'/>"/>

SOURCE Dr. Jay Calvert MD - Los Angeles Plastic Surgeon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Catholic Health Initiatives Makes $10 Million Investment in Calvert Foundations Community Investment Notes
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: